Profiel
Dr. Richard B.
Gayle is on the Board of Directors at Etubics Corp.
Dr. Gayle was previously employed as Senior Scientist by Immunex Corp.
He also served on the board at Sustainable Path Foundation.
He received his undergraduate degree from Rice University and a doctorate degree from the California Institute of Technology.
Eerdere bekende functies van Richard B. Gayle
| Bedrijven | Functie | Einde |
|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 |
| Sustainable Path Foundation | Oprichter | - |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Directeur/Bestuurslid | - |
Opleiding van Richard B. Gayle
| Rice University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Health Technology |
| Sustainable Path Foundation |
